Lilly’s Triple Agonist Retatrutide Holds Its Own In Type 2 Diabetes

 
• By Jessica Merrill
  
(Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapy Areas